Case and Research Letter
Individualized, Adjuvant-Intensified Immunocryosurgery for the Treatment of Squamous Cell Carcinoma in the Oldest Old: An Exploratory Case Series
Inmunocriocirugía individualizada intensificada con adyuvantes para el tratamiento del carcinoma de células escamosas en el anciano: una serie de casos exploratorios
G. Gaitanis
, C. Vlachos, I.D. Bassukas
Autor para correspondencia
Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece
Leído
2824
Vecesse ha leído el artículo
1208
Total PDF
1616
Total HTML
Compartir estadísticas
array:25 [ "pii" => "S0001731022002095" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.07.019" "estado" => "S300" "fechaPublicacion" => "2022-07-01" "aid" => "2981" "copyright" => "AEDV" "copyrightAnyo" => "2022" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113:750-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S0001731022005191" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.06.007" "estado" => "S300" "fechaPublicacion" => "2022-07-01" "aid" => "3086" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113:T750-T753" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICO-CLÍNICA</span>" "titulo" => " Inmunocriocirugía individualizada intensificada con adyuvantes para el tratamiento del carcinoma de células escamosas en el anciano: una serie de casos exploratorios" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "T750" "paginaFinal" => "T753" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Individualized, Adjuvant-Intensified Immunocryosurgery for the Treatment of Squamous Cell Carcinoma in the Oldest Old: An Exploratory Case Series" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1185 "Ancho" => 1300 "Tamanyo" => 201312 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Panel A) Presentación inicial del Tumor 1 localizado en la zona media del cuero cabelludo (Paciente 1). El tumor tenía un diámetro máximo de 20 mm y fue una recaída de una cirugía previa de hace 10 años. Panel B) Después del «ciclo de tratamiento 7/2» inicial (7 semanas de imiquimod y criocirugía en los días 24 y 28 del ciclo de tratamiento) se logró una respuesta parcial del tumor. Panel C) El área tumoral después del segundo ciclo de tratamiento de cinco semanas de imiquimod y una sesión de criocirugía («ciclo 5/1»). Panel D) Respuesta completa mantenida tras los 30 meses de seguimiento.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "G. Gaitanis, C. Vlachos, I.D. Bassukas" "autores" => array:3 [ 0 => array:2 [ "nombre" => "G." "apellidos" => "Gaitanis" ] 1 => array:2 [ "nombre" => "C." "apellidos" => "Vlachos" ] 2 => array:2 [ "nombre" => "I.D." "apellidos" => "Bassukas" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022005191?idApp=UINPBA000044" "url" => "/00017310/0000011300000007/v1_202207140532/S0001731022005191/v1_202207140532/es/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0001731022005166" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.02.031" "estado" => "S300" "fechaPublicacion" => "2022-07-01" "aid" => "3083" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113:T748-T749" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científico-clínica</span>" "titulo" => " El papel de las asociaciones dermatológicas europeas en la promoción de políticas favorables a la maternidad durante la residencia en dermatología" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "T748" "paginaFinal" => "T749" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "The Role of the European Dermatological Associations in the Promotion of Maternity-Friendly Policies During the Dermatology Residency" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "K.M. Plachouri, F. Mulita, S. Georgiou" "autores" => array:3 [ 0 => array:2 [ "nombre" => "K.M." "apellidos" => "Plachouri" ] 1 => array:2 [ "nombre" => "F." "apellidos" => "Mulita" ] 2 => array:2 [ "nombre" => "S." "apellidos" => "Georgiou" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022005166?idApp=UINPBA000044" "url" => "/00017310/0000011300000007/v1_202207140532/S0001731022005166/v1_202207140532/es/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S0001731022005191" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.06.007" "estado" => "S300" "fechaPublicacion" => "2022-07-01" "aid" => "3086" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113:T750-T753" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICO-CLÍNICA</span>" "titulo" => " Inmunocriocirugía individualizada intensificada con adyuvantes para el tratamiento del carcinoma de células escamosas en el anciano: una serie de casos exploratorios" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "T750" "paginaFinal" => "T753" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Individualized, Adjuvant-Intensified Immunocryosurgery for the Treatment of Squamous Cell Carcinoma in the Oldest Old: An Exploratory Case Series" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1185 "Ancho" => 1300 "Tamanyo" => 201312 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Panel A) Presentación inicial del Tumor 1 localizado en la zona media del cuero cabelludo (Paciente 1). El tumor tenía un diámetro máximo de 20 mm y fue una recaída de una cirugía previa de hace 10 años. Panel B) Después del «ciclo de tratamiento 7/2» inicial (7 semanas de imiquimod y criocirugía en los días 24 y 28 del ciclo de tratamiento) se logró una respuesta parcial del tumor. Panel C) El área tumoral después del segundo ciclo de tratamiento de cinco semanas de imiquimod y una sesión de criocirugía («ciclo 5/1»). Panel D) Respuesta completa mantenida tras los 30 meses de seguimiento.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "G. Gaitanis, C. Vlachos, I.D. Bassukas" "autores" => array:3 [ 0 => array:2 [ "nombre" => "G." "apellidos" => "Gaitanis" ] 1 => array:2 [ "nombre" => "C." "apellidos" => "Vlachos" ] 2 => array:2 [ "nombre" => "I.D." "apellidos" => "Bassukas" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022005191?idApp=UINPBA000044" "url" => "/00017310/0000011300000007/v1_202207140532/S0001731022005191/v1_202207140532/es/main.assets" ] ] "en" => array:16 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>" "titulo" => "Individualized, Adjuvant-Intensified Immunocryosurgery for the Treatment of Squamous Cell Carcinoma in the Oldest Old: An Exploratory Case Series" "tieneTextoCompleto" => true "saludo" => "To the Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "750" "paginaFinal" => "753" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "G. Gaitanis, C. Vlachos, I.D. Bassukas" "autores" => array:3 [ 0 => array:4 [ "nombre" => "G." "apellidos" => "Gaitanis" "email" => array:1 [ 0 => "ggaitan@uoi.gr" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "C." "apellidos" => "Vlachos" ] 2 => array:2 [ "nombre" => "I.D." "apellidos" => "Bassukas" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Inmunocriocirugía individualizada intensificada con adyuvantes para el tratamiento del carcinoma de células escamosas en el anciano: una serie de casos exploratorios" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1185 "Ancho" => 1300 "Tamanyo" => 201312 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Panel (A): Initial presentation of the Tumor 1 in the mid-scalp (Patient 1). The tumor had a maximal diameter of 20<span class="elsevierStyleHsp" style=""></span>mm and was a relapse from a previous surgery 10 years ago. Panel (B): After the initial ‘7/2 treatment cycle’ (7-weeks of imiquimod and cryosurgery at days 24 and 28 of the treatment cycle) a partial response of the tumor was achieved. Panel (C): The tumor area after the second treatment cycle of 5 weeks imiquimod and 1 cryosurgery session (‘5/1 cycle’). Panel (D): Sustained complete clearance at 30-month follow up.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The approach to the ‘oldest-old’ patients (patients older than 85 years-of-age) with cutaneous squamous cell carcinoma (cSCC) must be adapted to the unavoidable presence of comorbidities, the inevitable decline of the physical and cognitive ability for self-support and the limited life-expectancy.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">cSCC is a potentially life threating tumor that preferentially affects the ‘oldest old’,<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> a fact that often instigates individualized approaches. For primary cSCC first-line treatment is surgery either with clinically predefined margins or Mohs.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> However, the increasing frailty of these patients coupled with life-expectancy considerations substantially limit the applicability of radical, curative surgery, increasing the attractiveness of less-invasive, yet effective, therapeutic modalities.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Herein, we compile the preliminary findings of an open-label study on the treatment of locally confined cSCC in four patients over 85 years old with individualized, patient- and tumor-adapted immunocryosurgery modifications.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Patients were scheduled to be treated with an extended and intensified immunocryosurgery treatment protocol that included a more intense cryosurgery session (open spray liquid N<span class="elsevierStyleInf">2</span>, 2 freeze-thaw cycles, 30<span class="elsevierStyleHsp" style=""></span>s each vs 15<span class="elsevierStyleHsp" style=""></span>s for BCC<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a>) on days 14 and 28 of daily imiquimod application. Once daily imiquimod was to be resumed already on the same night and to be continued either for three more weeks (‘5/1 scheme’) or until the next cryosurgery session on day 28 and then for three more weeks (7 weeks imiquimod/2 cryosurgery sessions: ‘7/2 scheme’). Addition of optional adjuvants (intralesional methotrexate, tretinoin cream) was decided during the bi-weekly treatment course evaluation. Tretinoin cream 0.05% was added at week 2 only if minimal topical inflammatory tumor response was evident. Likewise, intralesional methotrexate was scheduled for the days of the cryosurgery sessions, yet with anticipated individualized adaptation. Treatment end and scheduled visits were planned as previously.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Eight biopsy-confirmed cSCC in four patients (3 males: 1 female, median age: 88 years [range: 85–89]) were treated on immunocryosurgery basis (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Different tumor-treatment trajectories with individualized adaptations of the prototype therapeutic scheme are presented below.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">Patient 1 (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>) was initiated with a ‘7/2 immunocryosurgery cycle’ with a partial tumor response (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>B). The tumor was eradicated with an additional, modified, ‘5/1 immunocryosurgery cycle’ (5-weeks imiquimod with an additional cryosurgery session at the last, 35th cycle's day, <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>C) and remained relapse free 30 months thereafter (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>D).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0035" class="elsevierStylePara elsevierViewall">Patient 2 initially presented with two cSCC (Tumors 2 and 3) which responded completely after parallel treatments with ‘7/2 immunocryosurgery cycles’ and two intralesional methotrexate injections (2.5<span class="elsevierStyleHsp" style=""></span>mg pro tumor and pro session at the cryosurgery days). Two smaller cSCC (Tumor 4 and 5) diagnosed during follow-up were treated with one standard ‘5/1 immunocryosurgery cycle’ each and adjuvant tretinoin cream. Relapses were not recorded for at least 12 months.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Patient 3 (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>) developed an intense inflammatory reaction after the first cryosurgery session of the ‘7/2 immunocryosurgery cycle’ with adjuvant 5<span class="elsevierStyleHsp" style=""></span>mg intralesional methotrexate and did not consent to it at the 2nd cryosurgery session at week 4. Instead, an additional week of imiquimod was scheduled to complete a ‘5/1week’ immunocryosurgery cycle’. The tumor responded partially (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>B) and at one-month follow-up a second ‘5/1 immunocryosurgery cycle’ without adjuvants resulted to complete tumor clearance (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>C) that persisted after 12 months follow up (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>D). At six months follow-up a second cSCC was diagnosed and treated with a ‘7/2 immunocryosurgery cycle’ with adjuvant methotrexate at the first cryosurgery session (Day 14). Subsequently the patient was lost to follow-up.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0045" class="elsevierStylePara elsevierViewall">Patient 4 presented with a rapidly growing cSCC on his left cheek (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). He initially denied surgical excision or radiotherapy. However, the neoplasm responded only partially to 14 weeks imiquimod application, 5 sessions of cryosurgery and 5 intralesional methotrexate injections (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Subsequently he consented to radiotherapy and remained tumor free at the six months follow-up.</p><p id="par0050" class="elsevierStylePara elsevierViewall">In total, from the eight cSCC, seven responded completely to augmented, time protracted and adjuvant-enhanced immunocryosurgery cycles. From these initially responders six tumor sites remained relapse-free for at least 12 months after treatment.</p><p id="par0055" class="elsevierStylePara elsevierViewall">To date, immunocryosurgery has been successfully applied to treat BCC,<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> Bowen's disease<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a> and lentigo maligna.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a> Immunocryosurgery was not considered a treatment option for cSCC, as cryosurgery ranks third line, mainly palliative modality, and imiquimod is not suggested for cSCC.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> However, the lasting efficacy of immunocryosurgery in the case of BCC is indicative of a synergistic interaction of imiquimod and cryosurgery within the proposed timing scheme with an underlying activation of immunostimulatory mechanisms both at tissue and at systemic levels.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">8</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">Surgery is not generally contraindicated in the oldest old although due to co-existing frailty often a not fully guideline-concordant surgical treatment may be applied.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">Conclusively, in this age group minimally invasive procedures, immunocryosurgery-based schemes or immunocryosurgery-like combinations of topicals (imiquimod, tretinoin cream and 2% 5-fluoruracil solution) with cryosurgery<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> offer the advantage of flexible approach to individualized treatment needs to improve feasibility and effectiveness with minimal treatment burden.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflict of interests</span><p id="par0070" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflict of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflict of interests" ] 1 => array:2 [ "identificador" => "xack616860" "titulo" => "Acknowledgements" ] 2 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1185 "Ancho" => 1300 "Tamanyo" => 201312 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Panel (A): Initial presentation of the Tumor 1 in the mid-scalp (Patient 1). The tumor had a maximal diameter of 20<span class="elsevierStyleHsp" style=""></span>mm and was a relapse from a previous surgery 10 years ago. Panel (B): After the initial ‘7/2 treatment cycle’ (7-weeks of imiquimod and cryosurgery at days 24 and 28 of the treatment cycle) a partial response of the tumor was achieved. Panel (C): The tumor area after the second treatment cycle of 5 weeks imiquimod and 1 cryosurgery session (‘5/1 cycle’). Panel (D): Sustained complete clearance at 30-month follow up.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1023 "Ancho" => 1300 "Tamanyo" => 351534 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Panel (A). Initial presentation of the Tumor 6 (Patient 3) in the midscalp. An intense inflammatory response after the first cryosurgery session of the ‘7/2 treatment cycle’ Panel (B). Tumor rests at the end of the first treatment cycle. Only partial response was noted. Panel (C). The tumor area at the end of the second treatment cycle. Panel (D) The tumor site at the 12-month follow-up. The healing process is excellent in an area that normally requires complex surgical reconstruction procedures.</p>" ] ] 2 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Abbreviations.</p>" "tablatextoimagen" => array:1 [ 0 => array:1 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Tumor \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Patient \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Age/gender \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Localization \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Diameter (mm) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Prior surgery \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Treatment cycles \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Imiquimod (weeks) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Cryo sessions \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Adjuvants \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Outcome \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Follow-up (months) \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">87 Male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Scalp \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">20 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10 years ago \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1st cycle: 7; 2nd cycle: 5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1st cycle: 2; 2nd cycle: 1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Clearance \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">42 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">85 Female \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cheek, left \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">15 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tre<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>; 2xMTX<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> (5<span class="elsevierStyleHsp" style=""></span>mg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Clearance \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">14 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Temple, left \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">11 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tre; 2xMTX (5<span class="elsevierStyleHsp" style=""></span>mg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Clearance \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">14 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cheek, right \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tre \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Clearance \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">12 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Nose, left \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tre \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Clearance \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">12 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">87 Male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Scalp \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">30 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1st cycle: 5; 2nd cycle: 5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1st cycle 1; 2nd cycle: 1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1st cycle: 1xMTX (5<span class="elsevierStyleHsp" style=""></span>mg); 2nd cycle: None \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Clearance \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">12 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Scalp \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">25 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1xMTX (5<span class="elsevierStyleHsp" style=""></span>mg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Clearance \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">89 Male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cheek, left \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">22 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1st cycle: 9; 2nd cycle: 5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1st cycle: 3; 2nd cycle: 2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1st cycle: 3xMTX(5<span class="elsevierStyleHsp" style=""></span>mg); 2nd cycle: 2xMTX(5<span class="elsevierStyleHsp" style=""></span>mg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Partial response-relapse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Tre: tretinoin cream.</p>" ] 1 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">MTX: methotrexate.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Clinical characteristics and therapeutical parameters of 8 cutaneous squamous cell carcinomas treated with immunocryosurgery (±adjuvants).</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0055" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comorbidity in older adults with cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G.R. Williams" 1 => "A. Mackenzie" 2 => "A.A. Magnuson" 3 => "R. Olin" 4 => "A. Chapman" 5 => "S. Mohile" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jgo.2015.12.002" "Revista" => array:6 [ "tituloSerie" => "J Geriatr Oncol" "fecha" => "2016" "volumen" => "7" "paginaInicial" => "249" "paginaFinal" => "257" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26725537" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0060" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cutaneous squamous cell carcinoma: an epidemiological review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.C. Green" 1 => "C.M. Olsen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/bjd.15324" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2017" "volumen" => "177" "paginaInicial" => "373" "paginaFinal" => "381" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28211039" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0065" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.J. Stratigos" 1 => "C. Garbe" 2 => "C. Dessinioti" 3 => "C. Lebbe" 4 => "V. Bataille" 5 => "L. Bastholt" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ejca.2020.01.008" "Revista" => array:6 [ "tituloSerie" => "Treat Eur J Cancer" "fecha" => "2020" "volumen" => "128" "paginaInicial" => "83" "paginaFinal" => "102" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32113942" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0070" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frailty and post-operative outcomes in older surgical patients: a systematic review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "H.S. Lin" 1 => "J.N. Watts" 2 => "N.M. Peel" 3 => "R.E. Hubbard" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s12877-016-0329-8" "Revista" => array:5 [ "tituloSerie" => "BMC Geriatr" "fecha" => "2016" "volumen" => "16" "paginaInicial" => "157" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27580947" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0075" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunocryosurgery for non-superficial basal cell carcinomas<span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>20<span class="elsevierStyleHsp" style=""></span>mm in maximal diameter: five-year follow-up" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "G. Gaitanis" 1 => "I.D. Bassukas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jgo.2018.08.012" "Revista" => array:4 [ "tituloSerie" => "J Geriatr Oncol" "fecha" => "2019" "paginaInicial" => "475" "paginaFinal" => "478" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0080" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunocryosurgery – an effective combinational modality for Bowen's disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "G. Gaitanis" 1 => "I.D. Bassukas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/dth.12371" "Revista" => array:6 [ "tituloSerie" => "Dermatol Ther" "fecha" => "2016" "volumen" => "29" "paginaInicial" => "334" "paginaFinal" => "337" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27272913" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0085" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Periocular lentigo maligna successfully treated with immunocryosurgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Oro-Ayude" 1 => "B. Gonzalez-Sixto" 2 => "J.M. Faraldo-Lorenzo" 3 => "C. Feal" 4 => "A. Flórez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/dth.14561" "Revista" => array:5 [ "tituloSerie" => "Dermatol Ther" "fecha" => "2021" "volumen" => "34" "paginaInicial" => "e14561" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33210813" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0090" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunocryosurgery for basal cell carcinoma: impact on circulating CD4<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>CD25 high T regulatory cells and serum cytokines" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "G. Gaitanis" 1 => "A. Ganiatsa" 2 => "G. Vartholomatos" 3 => "A. Karamoutsios" 4 => "P. Pappas" 5 => "I.D. Bassukas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1684/ejd.2020.3864" "Revista" => array:5 [ "tituloSerie" => "Eur J Dermatol" "fecha" => "2020" "volumen" => "30" "paginaInicial" => "605" "paginaFinal" => "606" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0095" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cancer statistics for adults aged 85 years and older, 2019" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.E. DeSantis" 1 => "K.D. Miller" 2 => "W. Dale" 3 => "S.G. Mohile" 4 => "H.J. Cohen" 5 => "C.R. Leach" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3322/caac.21577" "Revista" => array:6 [ "tituloSerie" => "CA Cancer J Clin" "fecha" => "2019" "volumen" => "69" "paginaInicial" => "452" "paginaFinal" => "467" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31390062" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0100" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Combination topical chemotherapy for the treatment of an invasive cutaneous squamous cell carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Fayne" 1 => "S. Nanda" 2 => "A. Nichols" 3 => "J. Shen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.36849/JDD. 2020.2228" "Revista" => array:6 [ "tituloSerie" => "J Drugs Dermatol" "fecha" => "2020" "volumen" => "19" "paginaInicial" => "202" "paginaFinal" => "204" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32155018" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack616860" "titulo" => "Acknowledgements" "texto" => "<p id="par0075" class="elsevierStylePara elsevierViewall">The authors wish to express their appreciation to Professor Petia Radeva for language editing.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/00017310/0000011300000007/v1_202207140532/S0001731022002095/v1_202207140532/en/main.assets" "Apartado" => array:4 [ "identificador" => "6143" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Cartas científico-clínicas" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011300000007/v1_202207140532/S0001731022002095/v1_202207140532/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022002095?idApp=UINPBA000044" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 4 | 9 | 13 |
| 2024 Octubre | 56 | 41 | 97 |
| 2024 Septiembre | 38 | 38 | 76 |
| 2024 Agosto | 60 | 54 | 114 |
| 2024 Julio | 47 | 32 | 79 |
| 2024 Junio | 50 | 33 | 83 |
| 2024 Mayo | 53 | 34 | 87 |
| 2024 Abril | 46 | 26 | 72 |
| 2024 Marzo | 51 | 39 | 90 |
| 2024 Febrero | 53 | 27 | 80 |
| 2024 Enero | 46 | 29 | 75 |
| 2023 Diciembre | 34 | 17 | 51 |
| 2023 Noviembre | 48 | 29 | 77 |
| 2023 Octubre | 45 | 32 | 77 |
| 2023 Septiembre | 47 | 20 | 67 |
| 2023 Agosto | 50 | 30 | 80 |
| 2023 Julio | 62 | 35 | 97 |
| 2023 Junio | 41 | 18 | 59 |
| 2023 Mayo | 55 | 34 | 89 |
| 2023 Abril | 34 | 36 | 70 |
| 2023 Marzo | 55 | 25 | 80 |
| 2023 Febrero | 40 | 32 | 72 |
| 2023 Enero | 48 | 44 | 92 |
| 2022 Diciembre | 56 | 49 | 105 |
| 2022 Noviembre | 62 | 37 | 99 |
| 2022 Octubre | 63 | 51 | 114 |
| 2022 Septiembre | 42 | 48 | 90 |
| 2022 Agosto | 84 | 55 | 139 |
| 2022 Julio | 119 | 75 | 194 |
| 2022 Junio | 27 | 30 | 57 |
| 2022 Mayo | 30 | 39 | 69 |
| 2022 Abril | 41 | 53 | 94 |
| 2022 Marzo | 29 | 57 | 86 |
Mostrar todo
